Cyclazodone-d5 – (1246817-86-6)

Cyclazodone is a centrally acting stimulant drug developed by the American Cyanamid Company in the 1960s. It is structurally related to pemoline and thozalinone, displaying a favorable therapeutic index and safety margin compared to pemoline and other N-lower-alkyl-substituted pemoline derivatives.

Cyclazodone has been noted for its potential to reduce fatigue and act as an anorectic. It is classified as an excitant with unique properties, showing less stimulatory activity and toxicity compared to amphetamine.

Safety information is limited as it has not been evaluated by the FDA for human use, though studies on mice suggest it exhibits less cardiotoxic and hepatotoxic effects than D-amphetamine.

The above information is displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Cyclazodone is a centrally acting stimulant drug developed by the American Cyanamid Company in the 1960s. It is structurally related to pemoline and thozalinone, displaying a favorable therapeutic index and safety margin compared to pemoline and other N-lower-alkyl-substituted pemoline derivatives.

Cyclazodone has been noted for its potential to reduce fatigue and act as an anorectic. It is classified as an excitant with unique properties, showing less stimulatory activity and toxicity compared to amphetamine.

Safety information is limited as it has not been evaluated by the FDA for human use, though studies on mice suggest it exhibits less cardiotoxic and hepatotoxic effects than D-amphetamine.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Cyclazodone
https://pubchem.ncbi.nlm.nih.gov/compound/136257838
https://www.medchemexpress.com/cyclazodone-d5.html

Other Names	Cyclopropyl Pemoline-d5, 2-cyclopropylimino-5-(2, 3, 4, 5, 6-pentadeuteriophenyl)-1, 3-oxazolidin-4-one, CyclopropylPemoline-d5
IUPAC Name	2-cyclopropylimino-5-(2, 3, 4, 5, 6-pentadeuteriophenyl)-1, 3-oxazolidin-4-one
CAS	1246817-86-6
Molecular Weight	221.27
Molecular Formula	C12H12N2O2
SMILES	[2H]C1=C(C(=C(C(=C1[2H])[2H])C2C(=O)NC(=NC3CC3)O2)[2H])[2H]

Products

Consulting & Services

Check Out Our Research And Updates

Cyclazodone-d5 – (1246817-86-6)

Cyclazodone is a centrally acting stimulant drug developed by the American Cyanamid Company in the 1960s. It is structurally related to pemoline and thozalinone, displaying a favorable therapeutic index and safety margin compared to pemoline and other N-lower-alkyl-substituted pemoline derivatives.

Cyclazodone has been noted for its potential to reduce fatigue and act as an anorectic. It is classified as an excitant with unique properties, showing less stimulatory activity and toxicity compared to amphetamine.

Safety information is limited as it has not been evaluated by the FDA for human use, though studies on mice suggest it exhibits less cardiotoxic and hepatotoxic effects than D-amphetamine.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Cyclazodone
https://pubchem.ncbi.nlm.nih.gov/compound/136257838
https://www.medchemexpress.com/cyclazodone-d5.html

About Us

Products

Services

Quick Contact

Check Out Our Research And Updates

Cyclazodone-d5 – (1246817-86-6)

Cyclazodone is a centrally acting stimulant drug developed by the American Cyanamid Company in the 1960s. It is structurally related to pemoline and thozalinone, displaying a favorable therapeutic index and safety margin compared to pemoline and other N-lower-alkyl-substituted pemoline derivatives.

Cyclazodone has been noted for its potential to reduce fatigue and act as an anorectic. It is classified as an excitant with unique properties, showing less stimulatory activity and toxicity compared to amphetamine.

Safety information is limited as it has not been evaluated by the FDA for human use, though studies on mice suggest it exhibits less cardiotoxic and hepatotoxic effects than D-amphetamine.

The above informationis displayed for information purpose only, and has not been reviewed by EON nor does EON attests or validates the accuracy nor does it constitutes a recommendation or validation.

Sources:

https://en.wikipedia.org/wiki/Cyclazodone https://pubchem.ncbi.nlm.nih.gov/compound/136257838 https://www.medchemexpress.com/cyclazodone-d5.html

Related products

Quick Contact

https://en.wikipedia.org/wiki/Cyclazodone
https://pubchem.ncbi.nlm.nih.gov/compound/136257838
https://www.medchemexpress.com/cyclazodone-d5.html